Naftidrofuryl


Full Prescribing Info
Dosage/Direction for Use

Oral
Cerebrovascular disorders
Adult: As oxalate: 100 mg tid.

Oral

Peripheral vascular disease
Adult: As oxalate: 100-200 mg tid.
Administration
Should be taken with food. Take w/ a large glass of water.
Contraindications
History of hyperoxaluria or recurrent calcium-containing stones.
Special Precautions
Patient should take sufficient amount of liquid during treatment.
Adverse Reactions
Nausea and epigastric pain, rash, hepatitis or hepatic failure, calcium oxalate stones.
Overdosage
Symptoms: Convulsions, depression of cardiac conduction. Management: Empty the stomach by gastric lavage and emesis. Activated charcoal may be used if needed. Monitor CV function and respiration. Electrical pacemaking or isoprenaline may be considered in severe cases. Diazepam may be used for convulsions.
Action
Naftidrofuryl produces dilatation of the blood vessels. It has been shown to enhanced cellular oxidative capacity by increasing ATP levels and reducing lactic acid levels in ischaemic conditions. It is also a potent spasmolytic agent.
Absorption: Well absorbed (oral). Peak plasma levels in about 30 min.
Distribution: Extensively bound to plasma proteins.
Excretion: Mainly via urine as metabolites. Half-life: About 1 hr.
Storage
Oral: Store below 20°C in a dry place away from light.
ATC Classification
C04AX21 - naftidrofuryl ; Belongs to the class of other peripheral vasodilators.
Disclaimer: This information is independently developed by CIMS based on naftidrofuryl from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in